SOAT1 and neoplasm: Despite potential drawbacks in research, JAK-STAT targeted CSC therapy is a novel research avenue with the future direction of curating personalized medicine treatment plans based on variations in JAK-STAT signaling among different tumor subtypes (Figure 4).